
The SARS-CoV-2 spike protein contains a DNA sequence identical to a genetic code patented by pharmaceutical company Moderna three years before the COVID pandemic emerged, according to researchers.
A study published in Frontiers in Virology on Monday by an international team of researchers found that the SARS-CoV-2 furin cleavage site (FCS) contains a tiny bit of genetic code identical to a part of a gene patented by Moderna in 2016.
The researchers claim that since there is a 1 in 3 TRILLION chance Moderna’s patented sequence randomly appeared through natural evolution, that the China Virus may have mutated during experiments on human cells in a lab.

“The absence of CTCCTCGGCGGGCACGTAG from any eukaryotic or viral genome in the BLAST database makes recombination in an intermediate host an unlikely explanation for its presence in SARS-CoV-2,” the scientists wrote.
Moderna’s patented sequence is part of a gene called MSH3, which is comprised of about 3,300 units of genetic code known as nucleotides.
The code the researchers found contains 19 of those same nucleotides out of the 30,000-nucleotide composition that makes up SARS-CoV-2.
“The presence in SARS-CoV-2 of a 19-nucleotide RNA sequence encoding an FCS at amino acid 681 of its spike protein with 100% identity to the reverse complement of a proprietary MSH3 mRNA sequence is highly unusual,” the researchers noted.
But some researchers are claiming the study doesn’t show anything meaningful.
Professor Lawrence Young, a supporter of the ineffective COVID vaccine, called the finding a “quirky” coincidence that doesn’t necessarily prove the China Virus is manmade.
“We’re talking about a very, very, very small piece made up of 19 nucleotides,” Young said. “So it doesn’t mean very much to be frank, if you do these types of searches you can always find matches.”
“It’s a quirky observation but I wouldn’t call it a smoking gun because it’s too small,” he added.
Earlier this month, Hungarian scientists discovered “traces of a unique variant of coronavirus while examining DNA from soil from Antarctica that had been sent to the firm Sangon Biotech in Shanghai,” the Daily Mail reported.
“The researchers also found genetic material from Chinese hamsters and green monkeys, which may suggest the virus was being examined in a lab, using either the animals themselves or their cells.”
This suggests coronavirus didn’t jump from wildlife into humans naturally, but was studied in a Chinese lab prior to its release.
Pfizer CEO Albert Bourla also recently admitted that his company’s mRNA vaccine was developed based on a lab-made version of SARS-CoV-2 rather than a naturally-occurring coronavirus.
“The data that we received are data that they got from what we call a pseudovirus, so it’s not the real virus, it is a virus that we have constructed in our labs and it is identical with the Omicron virus,” Bourla said.
The data from this latest study is just more evidence that contradicts the official narrative pushed by NIAID Director Anthony Fauci and EcoHealth Alliance President Peter Daszak that COVID-19 originated naturally from bats despite the WHO acknowledging that Patient Zero was likely a Wuhan lab worker.
Read the study:
Twitter: @WhiteIsTheFury
Gab: @WhiteIsTheFury
Minds: @WhiteIsTheFury
Gettr: @WhiteIsTheFury